Tae Joo Jeon

Dr. Tae Joo Jeon

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2014 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
SKShinae Kang
Shinae Kang
CKChanhee Kyung
Chanhee Kyung
JPJong Suk Park
Jong Suk Park
SKSohee Kim
Sohee Kim
SLSeung-Pyo Lee
Seung-Pyo Lee
CAChul Woo Ahn
Chul Woo Ahn
Although body mass index (BMI) is the most widely accepted parameter for defining obesity, recent studies have indicated a unique set of patients who exhibit normal BMI and excess body fat (BF), which is termed as normal weight obesity (NWO). Increased BF is an established risk factor for atherosclerosis. However, it is unclear whether NWO subjects already have a higher degree of vascular inflammation compared to normal weight lean (NWL) subjects; moreover, the association of BF with vascular inflammation in normal weight subjects is largely unknown. NWO and NWL subjects (n = 82 in each group) without any history of significant vascular disease were identified from a 3-year database of consecutively recruited patients undergoing 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (18 F-FDG-PET/CT) at a self-referred Healthcare Promotion Program. The degree of subclinical vascular inflammation was evaluated using the mean and maximum target-to-background ratios (TBRmean and TBRmax) of the carotid artery, which were measured by 18 F-FDG-PET/CT (a noninvasive tool for assessing vascular inflammation). We found that metabolically dysregulation was greater in NWO subjects than in NWL subjects, with a significantly higher blood pressure, higher fasting glucose level, and worse lipid profile. Moreover, NWO subjects exhibited higher TBR than NWL subjects (TBRmean: 1.33 ± 0.16 versus 1.45 ± 0.19, p < 0.001; TBRmax: 1.52 ± 0.23 versus 1.67 ± 0.25, p < 0.001). TBR was significantly associated with total BF (TBRmean: r = 0.267, p = 0.001; TBRmax: r = 0.289, p < 0.001), age (TBRmean: r = 0.170, p = 0.029; TBRmax: r = 0.165, p = 0.035), BMI (TBRmean: r = 0.184, p = 0.018; TBRmax: r = 0.206, p = 0.008), and fasting glucose level (TBRmean: r = 0.157, p = 0.044; TBRmax: r = 0.182, p = 0.020). In multiple linear regression analysis, BF was an independent determinant of TBRmean and TBRmax, after adjusting for age, BMI, and fasting glucose level (TBRmean: regression coefficient = 0.020, p = 0.008; TBRmax: regression coefficient = 0.028, p = 0.005). Compared to NWL, NWO was also independently associated with elevated TBRmax values, after adjusting for confounding factors (odds ratio = 2.887, 95% confidence interval 1.206–6.914, p = 0.017). NWO is associated with a higher degree of subclinical vascular inflammation, of which BF is a major contributing factor. These results warrant investigations for subclinical atherosclerosis in NWO patients.

1 September 2011 in Journal of Computer Assisted Tomography
Verified
Journal Article
Closed access
DKDae Jung Kim
Dae Jung Kim
JKJoo Hee Kim
Joo Hee Kim
YRYoung Hoon Ryu
Young Hoon Ryu
TJTae Joo Jeon
Tae Joo Jeon
JYJeong-Sik Yu
Jeong-Sik Yu
JCJae-Joon Chung
Jae-Joon Chung
To compare high-resolution pelvic magnetic resonance imaging (MRI) with positron emission tomography (PET)/computed tomography (CT) for the preoperative assessment of nodal staging in rectal cancer. Thirty patients who had surgery for rectal cancer were retrospectively enrolled during a 6-month period. Each patient underwent high-resolution pelvic MRI and PET/CT preoperatively within the same week. An experienced radiologist predicted nodal staging on MR, and an experienced nuclear medicine physician similarly predicted nodal staging on PET/CT. Their predictions were compared with pathologic staging results, retrospectively. The accuracies of nodal status prediction from MR and PET/CT were 83% and 70%, respectively. Magnetic resonance imaging had a sensitivity of 94% and a specificity of 67%, whereas PET/CT had a sensitivity of 61% and a specificity of 83%. A combination of MRI and PET/CT revealed a sensitivity of 94%, a specificity of 83%, and an accuracy of 90%. High-resolution pelvic MRI was more accurate than PET/CT for the prediction of regional nodal status. Magnetic resonance imaging had a high sensitivity and PET/CT had a high specificity for N staging in rectal cancer.


19 June 2015 in Synapse
Verified
Journal Article
Closed access
PDF file
MLMinkyung Lee
Minkyung Lee
YRYoung Hoon Ryu
Young Hoon Ryu
WCWon Gil Cho
Won Gil Cho
YKYeo Wool Kang
Yeo Wool Kang
SLSoo Jin Lee
Soo Jin Lee
JCJae Yong Choi
Jae Yong Choi

31 December 2014 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
SASung Gwe Ahn
Sung Gwe Ahn
JPJong Tae Park
Jong Tae Park
HLHak Woo Lee
Hak Woo Lee
TJTae Joo Jeon
Tae Joo Jeon
KHKyunghwa Han
Kyunghwa Han
JJJoon Jeong
Joon Jeong
Introduction: 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) can reveal the metabolic activity of malignant tumors. Recent advances gained from molecular studies suggest that tumor biology can be a good predictor of prognosis in breast cancer. We compared the ability of maximum standardized uptake values (SUVmax) derived by FDG-PET with tumor burden in predicting tumor recurrence for patients with breast cancer. Methods: 496 patients with breast cancer who underwent preoperative FDG-PET between April 2004 and May 2009 were retrospectively identified. SUVmax was obtained by FDG-PET, and the cutoff point was defined using a time-dependent receiver operating characteristic curve for recurrence-free survival (RFS). The primary endpoint was RFS. Results: In multivariate analysis for RFS, SUVmax carried independent prognostic significance (hazard ratio, 2.39; 95% confidence interval, 1.20 to 4.76; P = 0.012). When the patients were classified into four groups according to the combined factors of tumor size (≤2 cm versus >2 cm) and SUVmax (<4 versus ≥4), RFS differed significantly (P < 0.001). Similarly, SUVmax had prognostic value in combination with nodal status (negative versus positive) or stage (I versus II and III) (P < 0.001 and P = 0.001, respectively). In hormone receptor–positive disease, SUVmax remained a significant prognostic factor for RFS based on multivariate analysis. Conclusions: Our results highlight the prognostic value of FDG-PET in prediction of tumor relapse for patients with breast cancer. Particularly in patients with hormone receptor–positive disease, the tumor metabolic information provided by FDG-PET is more significantly correlated with prognosis than tumor burden.

9 September 2011 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
SASung Gwe Ahn
Sung Gwe Ahn
SKSung Hoon Kim
Sung Hoon Kim
TJTae Joo Jeon
Tae Joo Jeon
HCHojin Cho
Hojin Cho
SCSae Byeol Choi
Sae Byeol Choi
KKKyung Sik Kim
Kyung Sik Kim